The story of the withdrawal of the drug Augmentin which began last January:
In reality, as we wrote at the time, the story is true but it refers to a provision issued in 2014 and in the meantime the withdrawal has ended. The Aifa provision concerned packs of 12 coated tablets 875+125 mg. The withdrawal was ordered following reports from the companies GlaxoSmithKline and Medifarm, concerning internal labels in Romanian. Above all, the announcement of the withdrawal is dated December 5, 2014:
“05 DEC – AIFA transmits a provision concerning the withdrawal of a batch of the drug “AUGMENTIN 12 coated tablets 875+125 mg”, AIP n. 039785047. The withdrawal was ordered following reports from the companies GlaxoSmithKline and Medifarm, concerning internal labels in Romanian. Pending the withdrawal, the medicine cannot be used".
As in the case of Bisolven, therefore, the withdrawal concerns only a few well-specified lots. The problem, as reported in the letter, lies only in the fact that the internal labels are not in Italian.
